Danielle Skinner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Danielle Skinner has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Conor R. Caffrey
Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, USA
3 shared publications - John H. Wise
Georgia Institute of Technology
3 shared publications - Alexandra Probst
Swiss Tropical and Public Health Institute, Basel, Switzerland
2 shared publications - Corey Brummel-Smith
Center for Relativistic Astrophysics School of Physics Georgia Institute of Technology 30332 Atlanta GA USA
2 shared publications - Nelly El-Sakkary
Center for Discovery and Innovation in Parasitic Disease, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
2 shared publications - Snigdaa S. Sethuram
Center for Relativistic Astrophysics School of Physics Georgia Institute of Technology 30332 Atlanta GA USA
2 shared publications
Latest Publications
- Open Access
- 7 February 2024
- Published by Oxford University Press (OUP) in Monthly Notices of the Royal Astronomical Society
- Vol. 528 (4) , 5825-5835
Neutron star mergers and their impact on second generation star formation in the early universe
The exact evolution of elements in the universe, from primordial to heavier elements produced via the r-process, is still under scrutiny. The supernova deaths of the very first stars led to the enrichment of their local environments, and can leave behind neutron stars (NS) as remnants. These remnants can end up in binary systems with other NSs, and eventually merge, allowing for the r-process to occur. We study the scenario where a single NS merger (NSM) enriches a halo early in its evolution to understand the impact on the second generation of stars and their metal abundances. We perform a suite of high resolution cosmological zoom-in simulations using enzo where we have implemented a new NSM model varying the explosion energy and the delay time. In general, a NSM leads to significant r-process enhancement in the second generation of stars in a galaxy with a stellar mass of ∼105M⊙ at redshift 10. A high explosion energy leads to a Pop II mass fraction of 72% being highly enhanced with r-process elements, while a lower explosion energy leads to 80% being enhanced, but only 14% being highly enhanced. When the NSM has a short delay time of 10 Myr, only 5% of the mass fraction of Pop II stars is highly enhanced, while 64% is highly enhanced for the longest delay time of 100 Myr. This work represents a stepping stone towards understanding how NSMs impact their environments and metal abundances of descendant generations of stars.
- 7 February 2024
- Published by Oxford University Press (OUP) in Monthly Notices of the Royal Astronomical Society
- Vol. 528 (4) , 5825-5835
Open AccessNeutron star mergers and their impact on second generation star formation in the early universe
The exact evolution of elements in the universe, from primordial to heavier elements produced via the r-process, is still under scrutiny. The supernova deaths of the very first stars led to the enrichment of their local environments, and can leave behind neutron stars (NS) as remnants. These remnants can end up in binary systems with other NSs, and eventually merge, allowing for the r-process to occur. We study the scenario where a single NS merger (NSM) enriches a halo early in its evolution to understand the impact on the second generation of stars and their metal abundances. We perform a suite of high resolution cosmological zoom-in simulations using enzo where we have implemented a new NSM model varying the explosion energy and the delay time. In general, a NSM leads to significant r-process enhancement in the second generation of stars in a galaxy with a stellar mass of ∼105M⊙ at redshift 10. A high explosion energy leads to a Pop II mass fraction of 72% being highly enhanced with r-process elements, while a lower explosion energy leads to 80% being enhanced, but only 14% being highly enhanced. When the NSM has a short delay time of 10 Myr, only 5% of the mass fraction of Pop II stars is highly enhanced, while 64% is highly enhanced for the longest delay time of 100 Myr. This work represents a stepping stone towards understanding how NSMs impact their environments and metal abundances of descendant generations of stars.
- Open Access
Neutron Star Mergers and their Impact on Second Generation Star Formation in the Early Universe
The exact evolution of elements in the universe, from primordial to heavier elements produced via the r-process, is still under scrutiny. The supernova deaths of the very first stars led to the enrichment of their local environments, and can leave behind neutron stars (NS) as remnants. These remnants can end up in binary systems with other NSs, and eventually merge, allowing for the r-process to occur. We study the scenario where a single NS merger (NSM) enriches a halo early in its evolution to understand the impact on the second generation of stars and their metal abundances. We perform a suite of high resolution cosmological zoom-in simulations using Enzo where we have implemented a new NSM model varying the explosion energy and the delay time. In general, a NSM leads to significant r-process enhancement in the second generation of stars in a galaxy with a stellar mass of $\sim 10^5 \mathrm{M}_{\odot}$ at redshift 10. A high explosion energy leads to a Pop II mass fraction of 72% being highly enhanced with r-process elements, while a lower explosion energy leads to 80% being enhanced, but only 14% being highly enhanced. When the NSM has a short delay time of 10 Myr, only 5% of the mass fraction of Pop II stars is highly enhanced, while 64% is highly enhanced for the longest delay time of 100 Myr. This work represents a stepping stone towards understanding how NSMs impact their environments and metal abundances of descendant generations of stars.Open AccessNeutron Star Mergers and their Impact on Second Generation Star Formation in the Early Universe
The exact evolution of elements in the universe, from primordial to heavier elements produced via the r-process, is still under scrutiny. The supernova deaths of the very first stars led to the enrichment of their local environments, and can leave behind neutron stars (NS) as remnants. These remnants can end up in binary systems with other NSs, and eventually merge, allowing for the r-process to occur. We study the scenario where a single NS merger (NSM) enriches a halo early in its evolution to understand the impact on the second generation of stars and their metal abundances. We perform a suite of high resolution cosmological zoom-in simulations using Enzo where we have implemented a new NSM model varying the explosion energy and the delay time. In general, a NSM leads to significant r-process enhancement in the second generation of stars in a galaxy with a stellar mass of $\sim 10^5 \mathrm{M}_{\odot}$ at redshift 10. A high explosion energy leads to a Pop II mass fraction of 72% being highly enhanced with r-process elements, while a lower explosion energy leads to 80% being enhanced, but only 14% being highly enhanced. When the NSM has a short delay time of 10 Myr, only 5% of the mass fraction of Pop II stars is highly enhanced, while 64% is highly enhanced for the longest delay time of 100 Myr. This work represents a stepping stone towards understanding how NSMs impact their environments and metal abundances of descendant generations of stars. - Open Access
Inferred galaxy properties during Cosmic Dawn from early JWST photometry results
Early photometric results from JWST have revealed a number of galaxy candidates above redshift 10. The initial estimates of inferred stellar masses and the associated cosmic star formation rates are above most theoretical model predictions up to a factor of 20 in the most extreme cases, while this has been moderated after the recalibration of NIRCam and subsequent spectroscopic detections. Using these recent JWST observations, we use galaxy scaling relations from cosmological simulations to model the star formation history to very high redshifts, back to a starting halo mass of 10^7 solar masses, to infer the intrinsic properties of the JWST galaxies. Here we explore the contribution of supermassive black holes, stellar binaries, and an excess of massive stars to the overall luminosity of high-redshift galaxies. Despite the addition of alternative components to the spectral energy distribution, we find stellar masses equal to or slightly higher than previous stellar mass estimates. Most galaxy spectra are dominated by the stellar component, and the exact choice for the stellar population model does not appear to make a major difference. We find that four of the 12 high-redshift galaxy candidates are best fit with a non-negligible active galactic nuclei component, but the evidence from the continuum alone is insufficient to confirm their existence. Upcoming spectroscopic observations of z > 10 galaxies will confirm the presence and nature of high-energy sources in the early universe and will constrain their exact redshifts.
Open AccessInferred galaxy properties during Cosmic Dawn from early JWST photometry results
Early photometric results from JWST have revealed a number of galaxy candidates above redshift 10. The initial estimates of inferred stellar masses and the associated cosmic star formation rates are above most theoretical model predictions up to a factor of 20 in the most extreme cases, while this has been moderated after the recalibration of NIRCam and subsequent spectroscopic detections. Using these recent JWST observations, we use galaxy scaling relations from cosmological simulations to model the star formation history to very high redshifts, back to a starting halo mass of 10^7 solar masses, to infer the intrinsic properties of the JWST galaxies. Here we explore the contribution of supermassive black holes, stellar binaries, and an excess of massive stars to the overall luminosity of high-redshift galaxies. Despite the addition of alternative components to the spectral energy distribution, we find stellar masses equal to or slightly higher than previous stellar mass estimates. Most galaxy spectra are dominated by the stellar component, and the exact choice for the stellar population model does not appear to make a major difference. We find that four of the 12 high-redshift galaxy candidates are best fit with a non-negligible active galactic nuclei component, but the evidence from the continuum alone is insufficient to confirm their existence. Upcoming spectroscopic observations of z > 10 galaxies will confirm the presence and nature of high-energy sources in the early universe and will constrain their exact redshifts.
- 25 August 2023
- Published by Oxford University Press (OUP) in Monthly Notices of the Royal Astronomical Society
- Vol. 525 (3) , 4405-4425
Inferred galaxy properties during Cosmic Dawn from early JWST photometry results
Early photometric results from JWST have revealed a number of galaxy candidates above redshift 10. The initial estimates of inferred stellar masses and the associated cosmic star formation rates are above most theoretical model predictions up to a factor of 20 in the most extreme cases, while this has been moderated after the recalibration of NIRCam and subsequent spectroscopic detections. Using these recent JWST observations, we use galaxy scaling relations from cosmological simulations to model the star formation history to very high redshifts, back to a starting halo mass of 107 M⊙, to infer the intrinsic properties of the JWST galaxies. Here we explore the contribution of supermassive black holes, stellar binaries, and an excess of massive stars to the overall luminosity of high-redshift galaxies. Despite the addition of alternative components to the spectral energy distribution, we find stellar masses equal to or slightly higher than previous stellar mass estimates. Most galaxy spectra are dominated by the stellar component, and the exact choice for the stellar population model does not appear to make a major difference. We find that four of the 12 high-redshift galaxy candidates are best fit with a non-negligible active galactic nuclei component, but the evidence from the continuum alone is insufficient to confirm their existence. Upcoming spectroscopic observations of z > 10 galaxies will confirm the presence and nature of high-energy sources in the early universe and will constrain their exact redshifts.
- 25 August 2023
- Published by Oxford University Press (OUP) in Monthly Notices of the Royal Astronomical Society
- Vol. 525 (3) , 4405-4425
Inferred galaxy properties during Cosmic Dawn from early JWST photometry results
Early photometric results from JWST have revealed a number of galaxy candidates above redshift 10. The initial estimates of inferred stellar masses and the associated cosmic star formation rates are above most theoretical model predictions up to a factor of 20 in the most extreme cases, while this has been moderated after the recalibration of NIRCam and subsequent spectroscopic detections. Using these recent JWST observations, we use galaxy scaling relations from cosmological simulations to model the star formation history to very high redshifts, back to a starting halo mass of 107 M⊙, to infer the intrinsic properties of the JWST galaxies. Here we explore the contribution of supermassive black holes, stellar binaries, and an excess of massive stars to the overall luminosity of high-redshift galaxies. Despite the addition of alternative components to the spectral energy distribution, we find stellar masses equal to or slightly higher than previous stellar mass estimates. Most galaxy spectra are dominated by the stellar component, and the exact choice for the stellar population model does not appear to make a major difference. We find that four of the 12 high-redshift galaxy candidates are best fit with a non-negligible active galactic nuclei component, but the evidence from the continuum alone is insufficient to confirm their existence. Upcoming spectroscopic observations of z > 10 galaxies will confirm the presence and nature of high-energy sources in the early universe and will constrain their exact redshifts.
- Open Access
- 2 July 2020
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 75 (10) , 2925-2932
Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone
Treatment of schistosomiasis, a neglected disease, relies on just one partially effective drug, praziquantel. We revisited the 9-acridanone hydrazone, Ro 15-5458, a largely forgotten antischistosomal lead compound. Ro 15-5458 was evaluated in juvenile and adult Schistosoma mansoni-infected mice. We studied dose–response, hepatic shift and stage specificity. The metabolic stability of Ro 15-5458 was measured in the presence of human and mouse liver microsomes, and human hepatocytes; the latter also served to identify metabolites. Pharmacokinetic parameters were measured in naive mice. The efficacy of Ro 15-5458 was also assessed in S. haematobium-infected hamsters and S. japonicum-infected mice. Ro 15-5458 had single-dose ED50 values of 15 and 5.3 mg/kg in mice harbouring juvenile and adult S. mansoni infections, respectively. An ED50 value of 17 mg/kg was measured in S. haematobium-infected hamsters; however, the compound was inactive at up to 100 mg/kg in S. japonicum-infected mice. The drug-induced hepatic shift occurred between 48 and 66 h post treatment. A single oral dose of 50 mg/kg of Ro 15-5458 had high activity against all tested S. mansoni stages (1-, 7-, 14-, 21- and 49-day-old). In vitro, human hepatocytes produced N-desethyl and glucuronide metabolites; otherwise Ro 15-5458 was metabolically stable in the presence of microsomes or whole hepatocytes. The maximum plasma concentration was approximately 8.13 μg/mL 3 h after a 50 mg/kg oral dose and the half-life was approximately 4.9 h. Ro 15-5458 has high activity against S. mansoni and S. haematobium, yet lacks activity against S. japonicum, which is striking. This will require further investigation, as a broad-spectrum antischistosomal drug is desirable.
- 2 July 2020
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 75 (10) , 2925-2932
Open AccessEfficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone
Treatment of schistosomiasis, a neglected disease, relies on just one partially effective drug, praziquantel. We revisited the 9-acridanone hydrazone, Ro 15-5458, a largely forgotten antischistosomal lead compound. Ro 15-5458 was evaluated in juvenile and adult Schistosoma mansoni-infected mice. We studied dose–response, hepatic shift and stage specificity. The metabolic stability of Ro 15-5458 was measured in the presence of human and mouse liver microsomes, and human hepatocytes; the latter also served to identify metabolites. Pharmacokinetic parameters were measured in naive mice. The efficacy of Ro 15-5458 was also assessed in S. haematobium-infected hamsters and S. japonicum-infected mice. Ro 15-5458 had single-dose ED50 values of 15 and 5.3 mg/kg in mice harbouring juvenile and adult S. mansoni infections, respectively. An ED50 value of 17 mg/kg was measured in S. haematobium-infected hamsters; however, the compound was inactive at up to 100 mg/kg in S. japonicum-infected mice. The drug-induced hepatic shift occurred between 48 and 66 h post treatment. A single oral dose of 50 mg/kg of Ro 15-5458 had high activity against all tested S. mansoni stages (1-, 7-, 14-, 21- and 49-day-old). In vitro, human hepatocytes produced N-desethyl and glucuronide metabolites; otherwise Ro 15-5458 was metabolically stable in the presence of microsomes or whole hepatocytes. The maximum plasma concentration was approximately 8.13 μg/mL 3 h after a 50 mg/kg oral dose and the half-life was approximately 4.9 h. Ro 15-5458 has high activity against S. mansoni and S. haematobium, yet lacks activity against S. japonicum, which is striking. This will require further investigation, as a broad-spectrum antischistosomal drug is desirable.
- Open Access
- 29 May 2019
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 9, 180
Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
The protozoan parasite Entamoeba histolytica can induce amebic colitis and amebic liver abscess. First-line drugs for the treatment of amebiasis are nitroimidazoles, particularly metronidazole. Metronidazole has side effects and potential drug resistance is a concern. Schistosomiasis, a chronic and painful infection, is caused by various species of the Schistosoma flatworm. There is only one partially effective drug, praziquantel, a worrisome situation should drug resistance emerge. As many essential metabolic pathways and enzymes are shared between eukaryotic organisms, it is possible to conceive of small molecule interventions that target more than one organism or target, particularly when chemical matter is already available. Farnesyltransferase (FT), the last common enzyme for products derived from the mevalonate pathway, is vital for diverse functions, including cell differentiation and growth. Both E. histolytica and Schistosoma mansoni genomes encode FT genes. In this study, we phenotypically screened E. histolytica and S. mansoni in vitro with the established FT inhibitors, lonafarnib and tipifarnib, and with 125 tipifarnib analogs previously screened against both the whole organism and/or the FT of Trypanosoma brucei and Trypanosoma cruzi. For E. histolytica, we also explored whether synergy arises by combining lonafarnib and metronidazole or lonafarnib with statins that modulate protein prenylation. We demonstrate the anti-amebic and anti-schistosomal activities of lonafarnib and tipifarnib, and identify 17 tipifarnib analogs with more than 75% growth inhibition at 50 μM against E. histolytica. Apart from five analogs of tipifarnib exhibiting activity against both E. histolytica and S. mansoni, 10 additional analogs demonstrated anti-schistosomal activity (severe degenerative changes at 10 μM after 24 h). Analysis of the structure-activity relationship available for the T. brucei FT suggests that FT may not be the relevant target in E. histolytica and S. mansoni. For E. histolytica, combination of metronidazole and lonafarnib resulted in synergism for growth inhibition. Also, of a number of statins tested, simvastatin exhibited moderate anti-amebic activity which, when combined with lonafarnib, resulted in slight synergism. Even in the absence of a definitive molecular target, identification of potent anti-parasitic tipifarnib analogs encourages further exploration while the synergistic combination of metronidazole and lonafarnib offers a promising treatment strategy for amebiasis.
- 29 May 2019
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 9, 180
Open AccessBioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
The protozoan parasite Entamoeba histolytica can induce amebic colitis and amebic liver abscess. First-line drugs for the treatment of amebiasis are nitroimidazoles, particularly metronidazole. Metronidazole has side effects and potential drug resistance is a concern. Schistosomiasis, a chronic and painful infection, is caused by various species of the Schistosoma flatworm. There is only one partially effective drug, praziquantel, a worrisome situation should drug resistance emerge. As many essential metabolic pathways and enzymes are shared between eukaryotic organisms, it is possible to conceive of small molecule interventions that target more than one organism or target, particularly when chemical matter is already available. Farnesyltransferase (FT), the last common enzyme for products derived from the mevalonate pathway, is vital for diverse functions, including cell differentiation and growth. Both E. histolytica and Schistosoma mansoni genomes encode FT genes. In this study, we phenotypically screened E. histolytica and S. mansoni in vitro with the established FT inhibitors, lonafarnib and tipifarnib, and with 125 tipifarnib analogs previously screened against both the whole organism and/or the FT of Trypanosoma brucei and Trypanosoma cruzi. For E. histolytica, we also explored whether synergy arises by combining lonafarnib and metronidazole or lonafarnib with statins that modulate protein prenylation. We demonstrate the anti-amebic and anti-schistosomal activities of lonafarnib and tipifarnib, and identify 17 tipifarnib analogs with more than 75% growth inhibition at 50 μM against E. histolytica. Apart from five analogs of tipifarnib exhibiting activity against both E. histolytica and S. mansoni, 10 additional analogs demonstrated anti-schistosomal activity (severe degenerative changes at 10 μM after 24 h). Analysis of the structure-activity relationship available for the T. brucei FT suggests that FT may not be the relevant target in E. histolytica and S. mansoni. For E. histolytica, combination of metronidazole and lonafarnib resulted in synergism for growth inhibition. Also, of a number of statins tested, simvastatin exhibited moderate anti-amebic activity which, when combined with lonafarnib, resulted in slight synergism. Even in the absence of a definitive molecular target, identification of potent anti-parasitic tipifarnib analogs encourages further exploration while the synergistic combination of metronidazole and lonafarnib offers a promising treatment strategy for amebiasis.
- Open Access
- 5 April 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 599993
Quantifying the mechanics of locomotion of the schistosome pathogen with respect to changes in its physical environment
Schistosomiasis is a chronic and morbid disease of poverty affecting approximately 200 million people worldwide. Mature schistosome flatworms wander in the host’s hepatic portal and mesenteric venous system where they encounter a range of blood flow conditions and geometrical confinement. However, the mechanisms that support schistosome locomotion and underlie the pathogen’s adaptation to its physical environment are largely unknown. By combining microfabrication and traction force microscopy, we developed various in vitro assays to quantify the mechanics of locomotion of adult male S. mansoni in different physiologically relevant conditions. We show that in unconfined settings, the parasite undergoes two-anchor marching mediated by the coordinated action of its oral and ventral suckers. This mode of locomotion is maintained when the worm faces an external flow, to which it responds by adjusting the strength of its suckers. In geometrically confined conditions, S. mansoni switches to a different crawling modality by generating retrograde peristaltic waves along its body, a mechanism shared with terrestrial and marine worms. But while the surface of most worms has backward-pointing bristles that rectify peristaltic waves and facilitate forward locomotion, S mansoni has isotropically oriented tubercles. This requires tight coordination between muscle contraction and substrate friction but confers S. mansoni the ability to reverse its direction of locomotion without turning its body, which is likely advantageous to maneuver in narrow bore vessels. We show that the parasite can also coordinate the action of its suckers with its peristaltic body contractions to increase crawling speed. Throughout this study, we report on a number of biomechanical parameters to quantify the motility of adult schistosomes (e.g. sucker grabbing strength, rate of detachment under flow, peristaltic wave properties and traction stresses). The new series of in vitro assays make it possible to quantify key phenotypical aspects of S. mansoni motility that could guide the discovery of new drugs to treat schistosomiasis.
- 5 April 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 599993
Open AccessQuantifying the mechanics of locomotion of the schistosome pathogen with respect to changes in its physical environment
Schistosomiasis is a chronic and morbid disease of poverty affecting approximately 200 million people worldwide. Mature schistosome flatworms wander in the host’s hepatic portal and mesenteric venous system where they encounter a range of blood flow conditions and geometrical confinement. However, the mechanisms that support schistosome locomotion and underlie the pathogen’s adaptation to its physical environment are largely unknown. By combining microfabrication and traction force microscopy, we developed various in vitro assays to quantify the mechanics of locomotion of adult male S. mansoni in different physiologically relevant conditions. We show that in unconfined settings, the parasite undergoes two-anchor marching mediated by the coordinated action of its oral and ventral suckers. This mode of locomotion is maintained when the worm faces an external flow, to which it responds by adjusting the strength of its suckers. In geometrically confined conditions, S. mansoni switches to a different crawling modality by generating retrograde peristaltic waves along its body, a mechanism shared with terrestrial and marine worms. But while the surface of most worms has backward-pointing bristles that rectify peristaltic waves and facilitate forward locomotion, S mansoni has isotropically oriented tubercles. This requires tight coordination between muscle contraction and substrate friction but confers S. mansoni the ability to reverse its direction of locomotion without turning its body, which is likely advantageous to maneuver in narrow bore vessels. We show that the parasite can also coordinate the action of its suckers with its peristaltic body contractions to increase crawling speed. Throughout this study, we report on a number of biomechanical parameters to quantify the motility of adult schistosomes (e.g. sucker grabbing strength, rate of detachment under flow, peristaltic wave properties and traction stresses). The new series of in vitro assays make it possible to quantify key phenotypical aspects of S. mansoni motility that could guide the discovery of new drugs to treat schistosomiasis.